Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Follow up of a previous lecture
- Messages
- Overview
- What is exocytosis?
- Eukaryotes
- Inventions
- Endolysosome
- Lysosome
- Development of metazoans
- Quantal theory of neurotransmitter release
- Regulated exocytosis in astrocytes
- Electrophysiology & photolysis of caged calcium (1)
- Electrophysiology & photolysis of caged calcium (2)
- Electrophysiology & photolysis of caged calcium (3)
- Changing calcium in astrocytes
- Ca2+ dependence of the rate of exocytosis in various secretory cells
- Ca2+-dependent exocytosis in astrocytes (1)
- Regulated exocytosis requires the SNARE proteins
- Ca2+-dependent exocytosis in astrocytes (2)
- Microscopy studies
- Gliocrine astrocytes release a myriad of gliosignals via vesicles
- Vesicles and exocytosis
- Monitoring single vesicle fusion (discrete changes in Cm)
- Single-vesicle studies in astrocytes
- Two vesicle size populations in astrocytes
- Fusion pore conductance depends on vesicle diameter
- Vesicle cholesterol
- SNARE complex and vesicle cholesterol affect the transitions from reversible to full fusion
- SNAP-23 replaces SNAP-25 in astrocytes
- Ca2+-dependent exocytosis in astrocytes (3)
- Vesicle mobility
- Directional and non-directional mobility
- Directional mobility requires cytoskeletal elements
- Peptidergic vesicles
- Anti-VGLUT1 vesicle mobility in astrocytes
- Purinergic vesicles
- Reactive astrocytes
- Vesicle mobility & cytoskeletal filaments
- IFs and vesicle mobility
- Reactive astrogliosis in vitro
- Endolysosomal vesicle mobility
- Vesicle membrane interactions
- Summary
- Antigen presentation
- Reactive astrocytes in vitro
- IFNγ and reversible fusion of vesicles
- Mobility of MHC-II vesicles and intermediate filaments
- Conclusions
- Acknowledgements
Topics Covered
- Exocytosis
- Calcium-dependent exocytosis in astrocytes
- SNARE proteins
- Gliocrine astrocytes
- Vesicle fusion
- Vesicle cholesterol
- Vesicle mobility
- Peptidergic vesicles
- Purinergic vesicles
- Reactive astrocytes
- Reactive astrogliosis in vitro
- Vesicle membrane interactions
Links
Series:
Categories:
Therapeutic Areas:
External Links
Talk Citation
Zorec, R. (2023, September 28). Exocytosis and gliocrine astroglia [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/KAIJ6544.Export Citation (RIS)
Publication History
Financial Disclosures
- There are no commercial/financial disclosures.
A selection of talks on Physiology & Anatomy
Transcript
Please wait while the transcript is being prepared...
0:00
My name is Robert Zorec.
I'm from Ljubljana.
And today I will talk about
exocytosis in astrocytes.
0:11
I would like to
highlight that this is
a follow-up of a
previous lecture
on the properties of
exocytosis in astrocytes
that was recorded in 2014.
Let me tell you that
our lab is studying
pathophysiology at the
subcellular level,
including vesicles.
That actually brings us to
the topic that we
aim to translate.
We want to gain
knowledge by studying
membrane fusion and
vesicle dynamics.
Then the gained
results, we hope to be
employed in translating
this into medicines.
In the field of cancer,
we have already developed
a lysosomal heterologous fusion
in cell-based immunotherapy
to treat cancer.
This therapy is
already available and
it is approved in Slovenia.
This was done after
following a clinical trial.
In the domain of
neurological indications,
we would like to understand
vesicle-based signaling and
metabolism in astrocytes.
Which is then a
platform from which
we'd like to develop
small molecules that
target neuroglial
aerobic glycolysis
to be used in treating
various disorders
including neurodegeneration and
neurodevelopmental disorders.
This is the foreground
for the lecture today.
1:28
The first message is
that, like in neurons,
calcium-dependent exocytosis
exists in astrocytes.
It is controlled by
SNARE proteins and cholesterol,
but it is very slow.
Astrocytes act as
signal integrators.
The adaptation to regulate
homeostatic processes
in a slow-time domain,
as is the case in the
endocrine system,
brings us to the term
gliocrine system.
Astrocytes are part of
this very slow
regulating system,
hence called the
gliocrine system.
Astrocytes secrete
neurotransmitters,
a wide array of neuromodulators,
hormones, metabolic, trophic,
and plastic factors.
The release of these gliosignals
from astrocytes occurs
through distinct
pathways that include
diffusion through
plasmalemmal channels,
translocation by
multiple transporters,
and vesicle-based
regulated exocytosis.
That is the topic of
our lecture today.
These vesicles in astrocytes
are of different sizes.
At the end I'd like
to highlight that
lysosomal vesicle traffic is
altered in reactive astrocytes.